Plasma Osteopontin Velocity Differentiates Lung Cancers from Controls in a CT Screening Population

INTRODUCTION: As CT screening is integrated into non-small cell lung cancer (NSCLC) care, additional parameters are needed to help distinguish cancers from benign nodules. Osteopontin (OPN), a secreted phosphoprotein, has elevated plasma levels in NSCLC. We hypothesize that changes in plasma OPN ove...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Joseph, Sasha, Harrington, Ryan, Walter, Dawn, Goldberg, Judith D., Li, Xiaochun, Beck, Amanda, Litton, Tyler, Hirsch, Nathalie, Blasberg, Justin, Slomiany, Mark, Rom, William, Pass, Harvey, Donington, Jessica
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3746829/
https://ncbi.nlm.nih.gov/pubmed/23568008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/CBM-130306
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires